71 According to a report by the Center for Data Innovation, telehealth companies have been using advertising loopholes to promote stimulant medications to users on social media without the usual disclosures found in pharmaceutical ads. These companies are able to post ads for prescription drugs without including warnings or information about side effects due to discrepancies in pharmaceutical advertising laws and regulations. Many of the ads for stimulant medication on social media are targeted at individuals concerned about Attention Deficit and Hyperactivity Disorders. You Might Be Interested In SNB Capital and QMM Join Forces to Boost Saudi Exchange Liquidity and Growth Market Sentiment Gauge: Fear & Greed Index Shows Slight Relief, But Remains in Fear Zone Tesla Gears Up for Giant Factory Expansion in Texas Global Markets Await U.S. CPI Data Amidst Cautious Optimism; China’s Stocks Boosted by Sovereign Wealth Fund Moves Oxbotica Secures $140 Million in Funding to Revolutionize Transport Industry with Self-Driving Commercial Vehicles aiBANK Introduces aiPremier Elite: An Exclusive Segment Tailored for High-Net-Worth Clients